HDAC9 and cancer: Recently, histone deacetylase (HDAC) inhibitors have emerged as a promising new class of anticancer agents that act through a variety of mechanisms, including growth inhibition, cell cycle arrest, differentiation and apoptosis, in cancer cell lines.